Acute hepatitis C infection in a renal transplant recipient: Primacy of the liver or kidney?

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Althaf, Mohammed Mahdi ^a   Abdelsalam, Mohamed Said ^a,b   Rashwan, Mohamed ^a   Nadri, Quaid ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COMPLEMENT COMPONENT C4D; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTATIC HEPATITIS; CHRONIC HEPATITIS; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FATIGUE; FATTY LIVER; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; NAUSEA; NEPHRECTOMY; NONHUMAN; PERIPHERAL EDEMA; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEROCONVERSION; URINE VOLUME; VACCINATION; VIRUS DETECTION; VIRUS LOAD;

EID: 84901934726     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-203643     Document Type: Article

References (14)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1):S1-266.
2. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Int Med 2009;150:604-12.
3. Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
4. Abbott KC, Lentine KL, Bucci JR, et al. The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant 2004;4:2032-7. (Pubitemid 39611631)
5. Alghamdi SA, Nabi ZG, Alkhafaji DM, et al. Transplant tourism outcome: a single center experience. Transplantation 2010;90:184-8.
6. Reed AI, Merion RM, Roberts JP, et al. The declaration of Istanbul: review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee. Am J Transplant 2009;9:2466-9.
7. Bagheri A, Delmonico FL. Global initiatives to tackle organ trafficking and transplant tourism. Med Health Care Philos 2013;16:887-95.
8. Benner KG, Lee RG, Keeffe EB, et al. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992;103:1307-12.
9. Kidney disease: improving global outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008(109):S1-99.
10. Black M, Peters M. Alpha-interferon treatment of chronic hepatitis C: need for accurate diagnosis in selecting patients. Ann Intern Med 1992;116:86-8.
11. Fabrizi F, Lunghi G, Dixit V, et al. Meta-analysis: antiviral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther 2006;24:1413-22. (Pubitemid 44657117)
12. Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol 2008;49:613-24.
13. Shu KH, Lan JL, Wu MJ, et al. Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients. Transplantation 2004;77:1894-6.
14. Sanai FM, Mousa D, Al-Mdani A, et al. Safety and efficacy of peginterferon-alpha2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C. J Hepatol 2013;58:1096-103.